Literature DB >> 16792781

Improvement of psoriasis and cutaneous side-effects during tyrosine kinase inhibitor therapy for renal metastatic adenocarcinoma. A role for epidermal growth factor receptor (EGFR) inhibitors in psoriasis?

E Wierzbicka, J M Tourani, G Guillet.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16792781     DOI: 10.1111/j.1365-2133.2006.07299.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  6 in total

Review 1.  Tyrosine kinases in inflammatory dermatologic disease.

Authors:  Ricardo T Paniagua; David F Fiorentino; Lorinda Chung; William H Robinson
Journal:  J Am Acad Dermatol       Date:  2010-06-26       Impact factor: 11.527

Review 2.  Recent advances on the roles of epidermal growth factor receptor in psoriasis.

Authors:  Sijia Wang; Zhuoli Zhang; Han Peng; Kang Zeng
Journal:  Am J Transl Res       Date:  2019-02-15       Impact factor: 4.060

3.  Synergistic induction of IL-23 by TNFα, IL-17A, and EGF in keratinocytes.

Authors:  Benjamin Ehst; Zhiping Wang; Justin Leitenberger; Danielle McClanahan; Rachel De La Torre; Erika Sawka; Alex G Ortega-Loayza; Jennifer Strunck; Teri Greiling; Eric Simpson; Yuangang Liu
Journal:  Cytokine       Date:  2020-11-02       Impact factor: 3.861

4.  CCHCR1 is up-regulated in skin cancer and associated with EGFR expression.

Authors:  Sari Suomela; Outi Elomaa; Tiina Skoog; Risto Ala-aho; Leila Jeskanen; Jenita Pärssinen; Leena Latonen; Reidar Grénman; Juha Kere; Veli-Matti Kähäri; Ulpu Saarialho-Kere
Journal:  PLoS One       Date:  2009-06-24       Impact factor: 3.240

Review 5.  Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasis.

Authors:  Anja K Weidemann; Ania A Crawshaw; Emily Byrne; Helen S Young
Journal:  Clin Cosmet Investig Dermatol       Date:  2013-09-26

6.  JNK1 Signaling Downstream of the EGFR Pathway Contributes to Aldara®-Induced Skin Inflammation.

Authors:  Aurore Le; Abdulkader Azouz; Séverine Thomas; Nicolas Istaces; Muriel Nguyen; Stanislas Goriely
Journal:  Front Immunol       Date:  2021-02-05       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.